1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Discovery Research Grants in Bipolar Disorder - Cycle 4 is sponsored by BD² (Breakthrough Discoveries for Thriving with Bipolar Disorder). This program supports innovative and collaborative groups of multidisciplinary scientists to improve the understanding of the biological mechanisms that underlie bipolar disorder, examining genetic, molecular, cellular, circuit, and/or behavioral mechanisms.
Get alerted about grants like this
Save a search for “BD² (Breakthrough Discoveries for Thriving with Bipolar Disorder)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
RFA Opportunities - Breakthrough Discoveries (BD²) BD²: Breakthrough Discoveries for thriving with Bipolar Disorder funds science in search of ways to help every person with bipolar disorder thrive. We seek multidisciplinary teams to collaborate and explore the fundamental mechanisms, heterogeneity, progression, and underlying biology of the disorder to dramatically improve systems of care and accelerate research.
Since launch, BD² has invested $105M+ in research commitments. BD² Data Science Fellowship The BD² Data Science Fellowship supports postdoctoral researchers applying data science expertise to existing BD² datasets.
Fellows will work within BD²-funded teams or institutions to advance projects that generate new insights, develop computational tools, and strengthen the network’s ability to better understand the biology, trajectory, and mechanisms of bipolar disorder. Requests for Applications (RFAs) BD² Data Science Fellowship The BD² Data Science Fellowship supports postdoctoral researchers applying data science expertise to existing BD² datasets.
Fellows will work within BD²-funded teams or institutions to advance projects that generate new insights, develop computational tools, and strengthen the network’s ability to better understand the biology, trajectory, and mechanisms of bipolar disorder.
BD² Integrated Network Learning Health Network (LHN) Consultant BD² seeks applications from qualified organizations to serve as a consultant to the Integrated Network’s Learning Health Network (LHN).
The selected partner will provide strategic guidance and implementation support to help advance the LHN into a coordinated system that leverages real-world data and shared learning to improve care and outcomes for people living with bipolar disorder.
Discovery Research, Cycle 4 The Discovery Research program supports an innovative and collaborative group of researchers working together to improve our understanding of the biological mechanisms that underlie bipolar disorder.
For this funding cycle, we especially encourage applications that address the cellular and molecular mechanisms of mood-state switching; biological mechanisms by which manic or depressive episodes are induced by external risk factors; or using experimental pharmacology to test causality of a molecular or circuit-level mechanism underlying mood-state switching.
BD² Integrated Network Mobile Application Partner BD² seeks applications from qualified organizations or teams to develop and manage a comprehensive mobile application system for data collection, monitoring, and analysis for the Integrated Network. The BD² Integrated Network is part of a multidisciplinary initiative to increase the scientific understanding and, ultimately, to improve care and interventions for bipolar disorder.
BD² Integrated Network Site, Wave 2 The BD² Integrated Network, in partnership with people living with bipolar disorder and their care teams, engages a network of collaborating investigators and clinicians to build an unprecedented data ecosystem for bipolar disorder, implement and inform data-driven improvements in care, and generate novel insights for interventional approaches.
Discovery Research, Cycle 3 The Discovery Research program aims to delineate the etiology and biological mechanisms of bipolar disorder, allowing the development of effective interventions. We fund multidisciplinary teams of scientists and clinicians who generate new hypotheses and drive innovation in the exploration of causal mechanisms of bipolar disorder with an eye toward novel treatments.
Discovery Research, Cycle 2 The Discovery Research program supports an innovative and collaborative group of researchers working together to improve our understanding of the biological mechanisms that underlie bipolar disorder.
We seek multidisciplinary teams of scientists to develop targeted and groundbreaking research applications that will examine the genetic, molecular, cellular, circuit, and/or behavioral mechanisms of bipolar disorder.
BD² Integrated Network Clinical Coordinating Center (CCC) As part of the BD² Integrated Network, the CCC provides expert guidance and logistical support including key diagnostics and clinical assessments, Institutional Review Board activities, a rigorous study monitoring plan, and coordination of clinical care activities.
According to the current listing, eligibility includes: Teams of three to five scientists at academic institutions or research institutes. Confirm the full requirements in the official notice before applying.
Discovery Research Grants in Bipolar Disorder - Cycle 4 is funded by BD² (Breakthrough Discoveries for Thriving with Bipolar Disorder). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
S. 3971 reauthorized SBIR/STTR through 2031 after the longest lapse in the program's history. Buried inside are a new $30M Strategic Breakthrough Award, per-company proposal caps arriving in FY2027, eight-watchlist foreign-risk screening, and bigger TABA budgets. Here is what each change means for who wins and who gets squeezed out.
Read articleNSF restarted its SBIR/STTR programs on May 31, 2026 after a multi-month hiatus, with a $250 million FY26 allocation, a Project Pitch portal reopen on June 2, and a first full-proposal deadline of July 27, 2026. The big structural changes: a new Strategic Breakthrough tier that extends invited Phase II companies up to $30 million, and a $40 million pilot for next-generation scientific instrumentation. Phase I tops out at $305K, Phase II at $1.25M, with November 4 and March 4, 2027 windows behind the July 27 first deadline. For deep-tech startups that watched the NIH SBIR omnibus go dark and DARPA pull back on conventional Phase II slots, this is the most consequential reopening of the year — and the Strategic Breakthrough tier is the first time NSF has competed directly with venture capital at growth-stage check sizes.
Read articleOn May 31, NSF announced the restart of its SBIR and STTR programs with a \$250 million FY26 allocation, a Project Pitch portal reopening June 2, a first full-proposal deadline of July 27, 2026, and additional windows on November 4 and March 4, 2027. Phase I tops out at \$305K, Phase II at \$1.25M, and a new Strategic Breakthrough lane extends invited Phase II companies up to \$30M. A separate \$40M instrumentation pilot (NSF 26-511) funds next-generation scientific tools. Here is what changed from prior cycles, who the program actually fits, and how to position a Project Pitch for the July deadline.
Read article